{
    "prompt": "Please provide each treatment as a json format with the following JSON schema.\n    {\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\":\n            \"Link to FDA-approved Label\": \n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0059937\nAge: 78\nGender: Female\nSample ID: P-0059937-T01-IM7\nGene Panel: IMPACT505\nCancer Type: Pancreatic Adenocarcinoma\nSample Type: Primary\nTumor Purity: 30.0%\n=============\nDNA Variants:\nARID2 c.4708A>G (p.I1570V) - in 8.00% of 435 reads\nKDM6A c.3474del (p.N1158Kfs*20) - in 9.00% of 419 reads\nKRAS c.35G>T (p.G12V) - in 9.00% of 339 reads\nSMAD4 c.368del (p.C123Lfs*6) - in 10.00% of 355 reads\nSMARCA4 c.4066C>T (p.R1356W) - in 8.00% of 486 reads\nTP53 c.524G>A (p.R175H) - in 10.00% of 452 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Treatment 1\": {\n    \"Disease Name\": \"Pancreatic Adenocarcinoma\",\n    \"Disease Phase or Condition\": \"Advanced or Metastatic\",\n    \"Drug Name\": \"FOLFIRINOX (fluorouracil, irinotecan, oxaliplatin, leucovorin)\",\n    \"Prior Treatment or Resistance Status\": \"First-line treatment for metastatic pancreatic cancer\",\n    \"Genomic Features\": \"KRAS G12V mutation (p.G12V), TP53 mutation (p.R175H), SMAD4 mutation, ARID2 mutation, KDM6A mutation, SMARCA4 mutation\",\n    \"Link to FDA-approved Label\": \"https://www.fda.gov/drugs/resources-information-approved-drugs/folfirinox\"\n  }\n}"
}